Traweek S T, Liu J, Johnson R M, Winberg C D, Rappaport H
James Irvine Center for the Study of Leukemia and Lymphoma, City of Hope National Medical Center, Duarte, CA 91010.
Am J Clin Pathol. 1993 Nov;100(5):519-26. doi: 10.1093/ajcp/100.5.519.
The abrupt appearance of a high-grade tumor in patients with low-grade malignant lymphoma usually is associated with an accelerated clinical disease course. The high-grade lymphoma may take a variety of histologic forms and often, but not always, represents evolution of the original low-grade disease, as shown by immunophenotypic or immunogenotypic studies. The authors describe the transformation of a variety of low-grade B-cell neoplasms to high-grade tumors in four patients. The initial diagnoses included chronic lymphocytic leukemia and mantle cell lymphoma in one patient each and low-grade follicular lymphoma in two patients. The high-grade tumors were classified as lymphoblastic lymphoma in one patient and small noncleaved cell lymphoma in two patients. The high-grade component manifests primarily in the peripheral blood as circulating blast-like cells consistent with large-cell lymphoma in the remaining patient. In each case, immunophenotypic studies showed identical monoclonal surface immunoglobulin expression on the low- and high-grade tumors. Immunoglobulin heavy chain gene and kappa light chain gene studies showed identical clonally rearranged bands in paired samples from three of the four patients, a finding indicative of clonal identity. Unexpectedly, dissimilar immunoglobulin light and heavy chain gene rearrangements were detected in the paired samples from one patient with previously diagnosed follicular lymphoma, making the relationship of the two tumors from this patient uncertain; however, additional Southern blot analysis of the bcl-2 gene showed identical rearrangements in both lesions. Furthermore, polymerase chain reaction across the t(14;18) major breakpoint region in both tumors amplified nucleotide fragments of identical size, confirming the clonal identity of the low- and high-grade lymphomas despite the divergent immunoglobulin gene studies. These studies show that low-grade malignant lymphomas of small lymphocytic, mantle cell, or follicular small cleaved cell types may assume high-grade morphologic characteristics, that this change is the result of transformation of the preexisting low-grade malignant neoplasm, and that this progression, like typical Richter's syndrome, is associated with a dramatically accelerated clinical course. In addition, these studies confirm previous reports that disparate immunoglobulin light and heavy chain gene rearrangements are not necessarily an indicator of different cellular origins, and additional genotypic studies occasionally may be required to show the clonal identity of the cell population involved in these morphologic transformations.(ABSTRACT TRUNCATED AT 400 WORDS)
在低度恶性淋巴瘤患者中,高级别肿瘤的突然出现通常与临床病程加速相关。高级别淋巴瘤可能呈现多种组织学形式,并且通常(但并非总是)代表原始低度疾病的进展,免疫表型或免疫基因型研究已证实这一点。作者描述了4例患者中多种低度B细胞肿瘤向高级别肿瘤的转化。最初的诊断包括1例慢性淋巴细胞白血病、1例套细胞淋巴瘤以及2例低度滤泡性淋巴瘤。高级别肿瘤在1例患者中被分类为淋巴母细胞淋巴瘤,在2例患者中被分类为小无裂细胞淋巴瘤。在其余1例患者中,高级别成分主要在外周血中表现为与大细胞淋巴瘤一致的循环母细胞样细胞。在每种情况下,免疫表型研究显示低度和高级别肿瘤上存在相同的单克隆表面免疫球蛋白表达。免疫球蛋白重链基因和κ轻链基因研究显示,4例患者中有3例的配对样本中存在相同的克隆性重排条带,这一发现表明克隆同一性。出乎意料的是,在1例先前诊断为滤泡性淋巴瘤的患者的配对样本中检测到不同的免疫球蛋白轻链和重链基因重排,使得该患者的两种肿瘤之间的关系不确定;然而,对bcl-2基因进行的额外Southern印迹分析显示两个病变中存在相同的重排。此外,对两个肿瘤中t(14;18)主要断裂点区域进行的聚合酶链反应扩增出大小相同的核苷酸片段,尽管免疫球蛋白基因研究结果不同,但证实了低度和高级别淋巴瘤的克隆同一性。这些研究表明,小淋巴细胞、套细胞或滤泡性小裂细胞类型的低度恶性淋巴瘤可能呈现高级别形态特征,这种变化是先前存在的低度恶性肿瘤转化的结果,并且这种进展与典型的里氏综合征一样,与显著加速的临床病程相关。此外,这些研究证实了先前的报道,即不同的免疫球蛋白轻链和重链基因重排不一定表明细胞起源不同,有时可能需要进行额外的基因分型研究来显示参与这些形态学转化的细胞群体的克隆同一性。(摘要截选至400字)